Neuralink promises to help people with paralysis with brain chips
Elon Musk’s company has received a green light from the FDA to launch human clinical trials.
Neuralink, founded by Elon Musk and specializing in the design and manufacture of implantable brain-computer interfaces, received permission from FDA for the first human clinical trial.
About this company informed on his Twitter*: “We are excited to share with you that we have received FDA approval to launch our first human clinical trial! This is the result of the incredible work of the Neuralink team in close collaboration with the FDA and represents an important first step that will one day enable our technology to help many more people. Enrollment for our clinical trial is not yet open. We will announce more about it soon!”
Aim Neuralink is to create ultra-high-speed brain-computer interfaces that can connect the human brain to electronic devices. The company claims that its technology can help people with paralysis, as well as enhance a person’s cognitive and social capabilities. To do this, the company is developing special chips that are implanted in the skull using robotic surgery.
The company is already demonstrated working its chips on animals such as pigs and monkeys, and is now gearing up to move to human trials.
* The social network is prohibited on the territory of the Russian Federation